ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Surescripts First-Fill Abandonment Solution Empowers Providers with Insights to Help Improve Patient Care, Increase Medication Adherence and Advance Value-Based Care Performance

Partnership with Arcadia Will Help Accelerate Decisions and Keep Patient Care on Track

Surescripts®, the nation's leading health intelligence network, introduces First-Fill Abandonment solution to give provider organizations early insights about patient access to prescriptions when a medication goes unfilled, enabling care managers with faster and more accurate data to meaningfully address gaps in patients’ care and better support value-based care performance.

Equipped with earlier insights through First-Fill Abandonment, provider organizations will gain more power and precision to improve patient outcomes by tailoring their strategies based on patient-specific abandonment trends, including:

  • Locations with the highest abandonment rates inside a health system
  • Prescribers within a health system with the highest abandonment rates
  • Most frequently abandoned drugs from prescriptions written by the health system

“As a physician, prescribing a treatment is just one step in the patient care journey but once they leave the office, we typically do not have the ability to know if the patient has gotten the prescription we’ve written,” said Dr. Lynne Nowak, Chief Data and Analytics Officer for Surescripts. “It’s why we developed this solution and are excited to bring enhanced visibility to the next steps in the prescribing process, empowering care providers with meaningful insights, like when a patient does not pick up their medication, so they can perform faster, more targeted interventions to help keep patient care on track.”

More than 1 in 4 new prescriptions written are not filled due to a number of factors, including abandonment by patients, according to a report. First-Fill Abandonment delivers patient insights that help address the most common barriers to care: cost and access.

First-Fill Abandonment proactively compares new prescriptions sent across the Surescripts network and flags when a medication isn’t picked up by the patient. When a prescriber is notified that a patient hasn’t received a new medication, they can work with care coordinators and the patient to help address potential barriers that may lead to improved medication adherence and better care.

In addition to offering First-Fill Abandonment to health systems and electronic health records vendors, Surescripts is partnering with Arcadia, a leading healthcare data platform, to offer this product to their provider customers.

“In value-based care, even a single missed prescription can have a cascading effect on health outcomes, quality measures like HEDIS and Star ratings, and costs. We can’t afford to wait months for claims data to understand medication adherence,” said Michael Meucci, President and CEO of Arcadia. “By integrating near real-time First-Fill Abandonment insights from Surescripts into Arcadia’s platform, providers gain earlier visibility into when patients face barriers to starting therapy. This allows care teams to intervene faster, improve adherence, and ultimately deliver better results for patients and their organizations.”

With First-Fill Abandonment, provider organizations can:

  • Stay informed with a 12-month look-back period of first fill abandonment trends
  • Configure targeted first fill abandonment rates to align with their organization’s strategies for patient care
  • Evaluate medication-based care improvement initiatives
  • Uplift STARS & HEDIS measures focused on clinical outcomes

Learn more at HLTH:

Surescripts at HLTH 2025 – October 19-22, Las Vegas, NV

Stop by booth #2318, to learn more about how Surescripts is collaborating across healthcare, bringing innovative technology to care providers, delivering real-time insights, and automating administrative tasks to help keep patient care on track.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we bring healthcare together to inform and accelerate decisions, helping keep patient care on track. With the Surescripts Network Alliance®, we’re empowering the healthcare ecosystem with intelligence and interoperability for smarter, faster prescribing, prior authorization, treatment, care management and more. Visit us at surescripts.com and follow us on LinkedIn.

About Arcadia

Arcadia helps providers, payers, and government organizations transform healthcare data into predictive insights that drive better outcomes, increase revenue, and reduce costs. Its industry-leading platform amasses data from across the healthcare ecosystem and converts it into actionable analytics, AI-driven intelligence, and performance benchmarks, enabling smarter decisions and accelerating impact across the enterprise. National and regional health systems and payers, along with governmental organizations – including Aetna, Highmark Blue Cross Blue Shield, Intermountain Health, Ochsner Health, and the State of California – trust Arcadia to operationalize their data and lead the way in data-driven healthcare. Visit arcadia.io for more information.

Arcadia® is a trademark of Arcadia Solutions, LLC. All rights reserved.

"We are excited to bring enhanced visibility to the prescribing process, empowering care providers with meaningful insights so they can perform faster, more targeted interventions, helping keep patient care on track," said Dr. Lynne Nowak, Surescripts.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.16
-0.51 (-0.22%)
AAPL  277.55
+0.58 (0.21%)
AMD  214.24
+8.11 (3.93%)
BAC  52.99
+0.51 (0.97%)
GOOG  320.28
-3.36 (-1.04%)
META  633.61
-2.61 (-0.41%)
MSFT  485.50
+8.51 (1.78%)
NVDA  180.26
+2.44 (1.37%)
ORCL  204.96
+7.93 (4.02%)
TSLA  426.58
+7.18 (1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.